Related Experiment Video
Updated: Jun 10, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based
Annalisa Blasetti1, Concetta Di Giulio, Anna Maria Tocco
1Department of Pediatrics, University of Chieti, Via dei Vestini 5, Chieti, Italy. ablasetti@tiscalinet.it
Insights
Severe hypoglycemia (SH) in type 1 diabetes mellitus (T1DM) is linked to longer diabetes duration and specific insulin ratios. Patient education is key for SH prevention in children and adolescents.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Hypoglycemia is a significant challenge in type 1 diabetes mellitus (T1DM) management.
- Intensive T1DM treatment increases severe hypoglycemia (SH) risk.
- Understanding SH incidence and predictors in pediatric populations is crucial.
Purpose of the Study:
- To determine the incidence of severe hypoglycemia (SH) in children and adolescents with T1DM.
- To identify variables associated with SH in this demographic.
- To inform strategies for improved T1DM care and safety.
Main Methods:
- Prospective study over 7.5 years involving 195 pediatric T1DM patients.
- SH defined as blood glucose <50 mg/dL with altered consciousness.
- Data collected on HbA1c, insulin dose, regimen, duration, and age at onset.
Main Results:
- Overall SH incidence was 9.4 episodes per 100 patient-years.
- Predictors of SH included diabetes duration >10 years and basal/bolus insulin ratio >0.8.
- No significant association found between SH and HbA1c, daily insulin needs, or insulin regimen.
Conclusions:
- A relatively low incidence of SH was observed in this pediatric T1DM cohort.
- SH was primarily linked to diabetes management rather than glycemic control (HbA1c) or insulin therapy type.
- Patient and family education is emphasized as the primary strategy for SH prevention.
Objective:
Hypoglycemia remains a central problem in the management of type 1 diabetes mellitus (T1DM) and limits the achievement of good or normal glycemic control. The Diabetes Control and Complication Trial showed that intensive treatment of T1DM increased the risk of severe hypoglycemia (SH) when compared to conventional therapy. The aim of our study was to determine the incidence of SH and associated variables in a population of children and adolescents with T1DM.
Research Design And Methods:
We performed a 7.5-yr prospective study enrolling 195 patients aged 13.9 ± 6.6 yr. The study was carried out by referring to the T1DM population-based register in the Abruzzo region of Italy. The incidence of SH, defined as blood glucose levels <50 mg/dL (<2.77 mmol/L) associated with altered states of consciousness (including confusional state, seizures, and coma) was recorded. Glycated hemoglobin (HbA1c) percentage, insulin dose, insulin regimen, time since diagnosis, and age at onset were also recorded.
Results:
One hundred and thirty-three severe hypoglycemic events occurred during the study period; the overall incidence was 9.4 episodes per 100 patient-years. Significant predictors of hypoglycemia were diabetes duration >10 yr (p = 0.01), basal/bolus insulin ratio (ratio of daily basal insulin units to daily bolus insulin units) >0.8 (p = 0.01). No relationship was found between hypoglycemic episodes and HbA1c levels, daily insulin requirements, or insulin regimen.
Conclusions:
In these patients, a relatively low incidence of SH was recorded, without pronounced association with lower HbA1c or multiple daily injection insulin therapy. SH seems to be mainly related to management of diabetes. We believe that the main path to SH prevention is through patient and family education in the management of T1DM.
Related Concept Videos
Hypoglycemia
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational

